Development & Reproduction
Korean Society of Developmental Biology
Short communication

Effects of Nonylphenol on the Secretion of Catecholamines and Adrenocortical Hormones from Short-Term Incubated Rat Adrenal Glands

Hee-Su Kim1https://orcid.org/0000-0003-3716-4159, Yong-Pil Cheon2https://orcid.org/0000-0002-8497-9257, Sung-Ho Lee1,https://orcid.org/0000-0003-2866-3642
1Department of Biotechnology, Sangmyung University, Seoul 03016, Korea
2Division of Developmental Biology and Physiology, School of Biological Sciences and Chemistry, Sungshin University, Seoul 02844, Korea
Corresponding author Sung-Ho Lee, Department of Biotechnology, Sangmyung University, Seoul 03016, Korea, Tel: +82-2-2287-5139, Fax: +82-2-2287-0070, E-mail: shlee@smu.ac.kr

Copyright © 2023 The Korean Society of Developmental Biology. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creative-commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Sep 13, 2023 ; Revised: Oct 13, 2023 ; Accepted: Nov 18, 2023

Published Online: Dec 31, 2023

Abstract

Previously, we showed that a chronic-low-dose nonylphenol (NP) exposure resulted in histological changes with sexually dimorphic pattern in rat adrenal glands. We hypothesized that such structural changes are closely related to the hormonal secretory patterns. To test this hypothesis, we developed the short-term adrenal incubation method, and measured the levels of catecholamines and cortical steroids using the high-performance liquid chromatography with electrochemical detection (HPLC-ECD) and specific enzyme-linked immunosorbent assay, respectively. The norepinephrine (NE) levels in media from NP-treated female adrenal, except 100 pM NP, were significantly increased [control (CTL) vs 1 nM NP, p<0.001; vs 10 nM NP, p<0.05; vs 100 nM NP, p<0.001; vs 1 μM NP, p<0.01]. The NE secretion from male adrenal was higher when treated with 100 nM and 1 μM NP (CTL vs 100 nM NP, p<0.05; vs 1 μM NP, p<0.05, respectively). The aldosterone level in the female adrenal media treated with 100 pM NP was significantly decreased, on the other hand, that of media treated with 10 nM NP was significantly increased (CTL vs 100 pM NP, p<0.05; vs 10 nM NP, p<0.01). In male adrenal media, the aldosterone levels of 10 nM, 100 nM and 1 μM NP-treated media were significantly declined (CTL vs 10 nM NP, p<0.001; vs 100 nM NP, p<0.001; vs 1 μM NP, p<0.001). These results showed the NP treatment altered secretory pattern of aldosterone from adrenals of both sexes, showing sexual dimorphism. It may be helpful for understanding possible adrenal pathophysiology, and endocrine disrupting chemicals-related sexually dimorphic phenomena in adrenals.

Keywords: Nonylphenol; Adrenal organ culture; Aldosterone; Norepinephrine; Sexual dimorphism; Rats

INTRODUCTION

Mainstream of research on the endocrine disrupting chemicals (EDCs) has been reproductive toxicity, which is about the adverse effects of sex steroid-like substances on the hypothalamic-pituitary-gonadal (HPG) hormone axis and its target organs (Czarnywojtek et al., 2023). Since mammalian adrenal glands have steroid receptors, and share a high similarity with gonads in synthesize and secrete steroid hormones from cholesterol, the glands could be suitable for research on EDCs (Hinson & Raven, 2006; Lagunas et al., 2022). In fact, EDC studies on the adrenal gland have been gradually accumulating, although in much smaller amounts than on the gonads; these are including adrenal steroidogenesis disruption by diethylstilbestrol (DES) (Haeno et al., 2015), genistein-induced histomorphometric and hormone secreting changes in the adrenal cortex (Ajdžanović et al., 2009), corticosterone secretion changes by low-dose bisphenol-A (Lan et al., 2015), reduced pubertal development of cortex by triphenyltin chloride (Li et al., 2020), and disruption of cortical function by dipentyl phthalate (Chen et al., 2023). Previously, we also demonstrated that a chronic low-dose effect of Di (2-ethylhexyl) phthalate altered the histological characteristics and steroidogenic gene expression of adrenal gland in female mice (Lee et al., 2021), and nonylphenol (NP) exposure resulted in histological changes with sexually dimorphic pattern in rat adrenal glands (Kim & Lee, 2022). In the present study, we hypothesized that the structural changes are closely linked to functional changes, especially secretory function in rats, so the hormonal secretory patterns of NP treated adrenals might be changed. To test this hypothesis, we developed the short-term adrenal incubation method, and measured the catecholamines and cortical steroids in NP-treated media using the high-performance liquid chromatography (HPLC) coupled with electrochemical detector (ECD) and specific enzyme-linked immunosorbent assay (ELISA), respectively.

MATERIALS AND METHODS

1. Animals

Sprague-Dawley rats were provided by DBL (Eumseong, Korea) and reared in Sangmyung University animal facility under photoperiods of 12h light/dark with lights on at 7 AM and constant temperature of 21°C–23°C. Food and tap water were supplied ad libitum. The animal protocols were approved by the Animal Care and Use Committees at Sangmyung University (2018-03; approval number R-1801-1). All the animals received human care in accordance with the guides for animal experiments of the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.

2. Adrenal organ culture

The short-term organ culture was based on previous report (Mandon et al., 1987) with minor modification. Briefly, the adrenal glands of 8 weeks-old female and male rats were pre-incubated with a Krebs-Ringer Bicarbonate (KRB; Sigma-Aldrich, St. Louis, MO, USA) medium for 1 hour at 37°C in incubator (BINDER, Tuttlingen, Germany) aerated with 95% air and 5% CO2. Then the glands were shifted in fresh media and treated with NP (100 pM, 1 nM, 10 nM, 100 nM or 1 μM) for 1 hour at 37°C. After incubation, the media were centrifuged (10,000×g for 30 min at 4°C, Hanil, Gimpo, Korea) and the supernatants were stored at –80°C until analysis.

3. Hormone measurements
1) Corticosterone and aldosterone

The levels of corticosterone and aldosterone were measured by specific ELISA following supplier’s protocols (MyBioSource, San Diego, CA, USA). Briefly, standard and samples (50 μL) were added to each well and then add the detection reagent A solution (50 μL) immediately. The plate was incubated for 1 hour at 37°C, then the liquid was aspirated and washed 3 times with the wash solution (300 μL). After last washing, the remaining liquid was removed completely by aspirating or decanting and the detection reagent B solution (50 μL) was added to each well. The plate was incubated for 1 hour at 37°C. After incubation, the plate was washed 5 times as conducted previous washing step. The substrate solution (90 μL) was added to each well and the plate was incubated for 25 minutes at 37°C. When the liquid turned blue with the addition of the substrate solution, the stop solution (90 μL) was added to each well and mixed by tapping the side of the plate. The plate was measured at 450 nM using microplate reader immediately. The detection range of the corticosterone ELISA kit was 7.812–500 ng/mL and the aldosterone kit was 0.39–25 ng/mL, respectively.

2) Catecholamines

Measurements of catecholamine, including norepinephrine (NE) and epinephrine, were conducted with reverse-phase high-performance liquid chromatography with electrochemical detection (RP-HPLC-ECD) using methods modified from Wood & Hall (2000). The concentration range of NP treatment was determined through our preliminary experiments to reflect realistic exposure in daily life. The samples were centrifuged at 10,000×g for 10 min at 4°C to remove precipitated proteins. The supernatants were diluted by mobile phase buffer [0.01 N Formic acid (Shinyo Pure Chemicals, Osaka, Japan), 0.05 mM 1-Octanesulfonic acid sodium salt (Sigma-Aldrich), 10% Methanol (Honeywell, Morristown, NJ, USA)] before determining catecholamine content. The mobile phases were prepared as needed and degassed by sonicator (KODO Technical Research, Hwaseong, Korea) prior to use. Standards and samples were analyzed at room temperature using 5 μm Waters Xbridge C18 (150×4.6 mm I.D.) column (Waters, Milford, MA, USA). Injection volumes of samples and standard were 10 μL (2707 Auto sampler; Waters). The flowrate was 1 mL/minute over 20 minutes with an isocratic elution (1525 Binary HPLC Pump; Waters). Retention times of NE, epinephrine and dopamine were about 7, 9, and 11 minutes, respectively. Electrochemical detection was performed using model 2464 ECD [Waters; in situ Ag/AgCl (ISAAC; [Cl]=0.1 M)].

3) Statistical analysis

All experiments were performed at least three times. Values were expressed as mean±SE. Data were analyzed using Student’s t-test as indicated. p<0.05 was considered statistically significant. Calculations were performed using Graphpad Software Prism version 6.

RESULTS AND DISCUSSION

The NE and epinephrine levels of media were measured by HPLC. The NE levels of NP-treated media, except 100 pM NP, in which a female adrenal gland was cultured were significantly increased [Fig. 1A; control (CTL) vs 1 nM NP, 64.5±0.6 vs 68.5±0.2 ng/μL, p<0.001; vs 10 nM NP, vs 68.3±1.0 ng/μL, p<0.05; vs 100 nM NP, vs 69.8±0.2 ng/μL, p<0.001; vs 1 μM NP, vs 71.2±1.1 ng/μL, p<0.01]. The NE in male adrenal glands was more released when treated with 100 nM and 1 μM NP (Fig. 1C; CTL vs 100 nM NP, 49.8±3.0 vs 68.7±7.8 ng/μL, p<0.05; vs 1 μM NP, vs 59.3±0.8, p<0.05). However, epinephrine levels in both male and female adrenal media were not significantly changed (Fig. 1B and D).

dr-27-4-213-g1
Fig. 1. Effects of NP treatment on norepinephrine and epinephrine levels in cultured adrenal glands. The male and female rats were sacrificed at 8 weeks of age and their adrenal glands were removed. The removed adrenal glands were pre-incubated for 1 hr at 37°C in 500 μL Krebs-Ringer bicarbonate (KRB) modified buffer without NP. After pre-incubation, the adrenal glands were treated with NP at 100 pM, 1 nM, 10 nM, 100 nM and 1 μM for 1 hr at 37°C. The incubated media were collected and centrifuged to remove remaining tissue. The norepinephrine (A, female; C, male) and epinephrine (B, female; D, male) in media were measured by HPLC-ECD method. Values are shown as mean±SE. Significant differences are marked with an asterisk. * p<0.05; ** p<0.01; *** p<0.001; compared with the CTL. NP, nonylphenol; CTL, control group; HPLC-ECD, high-performance liquid chromatography with electrochemical detection.
Download Original Figure

The levels corticosterone and aldosterone in media were analyzed by ELISA. Significant changes of corticosterone levels in media from cultured female adrenal glands were not found (Fig. 2A). The corticosterone level of male adrenal media only treated with 100 pM NP was significantly lowered (Fig. 2C; CTL vs 100 pM NP, 139.4±1.6 vs 134.6±1.6 ng/mL, p<0.05). The aldosterone level in the female adrenal media treated with 100 pM NP was significantly decreased, while the level of media treated with 10 nM NP was significantly increased, showing an inverse manner (Fig. 2B; CTL vs 100 pM NP, 3.3±0.4 vs 2.6±0.03 ng/mL, p<0.05; vs 10 nM NP, vs 5.6±0.2 ng/mL, p<0.01). In male adrenal study, the aldosterone levels of 10 nM, 100 nM and 1 μM NP-treated media were significantly declined (Fig. 2D; CTL vs 10 nM NP, 4.7±0.3 vs 2.4±0.3 ng/mL, p<0.001; vs 100 nM NP, vs 2.2±0.2 ng/mL, p<0.001; vs 1 μM NP, vs 2.3±0.2 ng/mL, p<0.001).

dr-27-4-213-g2
Fig. 2. Effects of NP treatment on corticosterone and aldosterone levels in cultured adrenal glands. The male and female rats were sacrificed at 8 weeks of age and their adrenal glands were removed. The removed adrenal glands were pre-incubated for 1 hr at 37°C in 500 μL Krebs-Ringer bicarbonate (KRB) modified buffer without NP. After pre-incubation, the adrenal glands were treated with NP at 100 pM, 1 nM, 10 nM, 100 nM and 1 μM for 1 hr at 37°C. The incubated media were collected and centrifuged to remove remaining tissue. The corticosterone (A, female; C, male) and aldosterone (B, female; D, male) in media were measured by specific ELISA. Values are shown as mean±SE. Significant differences are marked with an asterisk. * p<0.05; ** p<0.01; *** p<0.001; compared with the CTL. NP, nonylphenol; ELISA, enzyme-linked immunosorbent assay; CTL, control.
Download Original Figure

In the present study, we developed rat adrenal organ culture system with simple serum-free KRB media for short-term period, and found this medium was suitable for detection of catecholamines and steroids, so EDC activity of NP could be easily verified. Treatment with NP altered secretory pattern of aldosterone from adrenals of both sexes. Intriguingly, NP treatment had a stimulatory effect on the female adrenal gland while had an inhibitory effect on the male adrenal gland, showing sexual dimorphism. In general, EDC has been known to have a negative effect on both males and females. Interestingly, these results suggest the possibility that the pathological effects of NP on rat adrenal glands are likely to occur only in one sex. In addition, NP treatment shown stimulatory effects on the NE secretions from adrenal medulla of both sexes, particularly resulted in more sensitive response at lower concentration in female adrenal gland, suggesting possible relationship between NP exposure and autonomic nervous system disorders.

It is now clear that hypothalamus-pituitary-thyroid, HPG, hypothalamus-pituitary-adrenal glands represent the main targets of EDCs (Gore et al., 2015; Kabir et al., 2015). Among these organs on the hormone axes, adrenal glands present favorable structural and biochemical features that make them ideal targets for EDCs (Lauretta et al., 2019). Adrenal glands, like gonads, are solid organ with a mechanism to synthesize and secrete steroid hormones and catecholamines. However, compared to the studies on gonads, only a small number of research have assessed the effects of EDC on the adrenal gland, although maintaining proper function of adrenal glands is crucial for maintaining life (Harvey, 2016). Nevertheless, data is gradually accumulating that major endocrine disruptors with reproductive toxicity also have adverse effects on the adrenal glands (Egalini et al., 2022). Adrenal glands possess estrogen receptors (ERalpha and ERbeta) and androgen receptor (AR), so estrogen-like or anti-androgenic substances can act as or disrupt the original ligands (Trejter et al., 2015). For example, the strong synthetic estrogen DES, which is known to bind ERs, substantially decreased the blood and adrenal corticosterone levels without any histological alteration (Haeno et al., 2015). Genistein, one of soybean phytoestrogen, can cause the shunting of metabolic pathways in the adrenals of orchidectomized middle-aged rats, stimulating dehydroepiandrosterone secretion and inhibiting corticosterone and aldosterone secretion (Ajdzanović et al., 2009). Treatment of mouse Y1 adrenal cortex cells with low doses of bisphenol-A (10–1,000 nM) increased promoter activity and protein expression of Cyp11a1, induced c-Jun phosphorylation, and increased corticosterone production (Lan et al., 2015). Oral administration of triphenyltin (0–2 mg/kg/day, for 18 days) inhibits production of corticosterone via blocking the expression of cholesterol uptake transporters and cholesterol biosynthesis in male pubertal rats (Li et al., 2020). In utero exposure to Di-n-pentyl phthalate (DPeP, 0–500 mg/kg/day) significantly reduced serum aldosterone and corticosterone levels, markedly reduced the thickness of zona glomerulosa, and significantly downregulated the expression of steroidogenesis- and apoptosis-related genes (Chen et al., 2023). Previously we also demonstrated that low-dose NP exposure induced early beginning of puberty and pathohistological abnormalities in ovary and uterus of F1 mice (Kim et al., 2020), and adrenal histology could be altered in F1 rats (Kim & Lee, 2022).

Among EDCs, NP has been relatively well studied using both in vivo and in vitro model systems. For example, NP exposure in developmental periods results in hyperadrenalism and increasing 11β-hydroxysteroid dehydrogenase I (11β-HSD1) activity in an adult rat model (Chang et al., 2010, 2018). In rat adrenal zona glomerulosa cell culture, treatment with NP increased aldosterone release, and this stimulatory effect seemed to be mediated through steroidogenic acute regulatory protein and aldosterone synthase activity (Chang et al., 2012). Another in vitro study (Yanagihara et al., 2005) revealed that NP significantly stimulated the catecholamine biosynthesis from tyrosine even at 0.1 nM and maximally at 10 nM, and increased tyrosine hydroxylase activity in the cultured bovine adrenal medulla cells. The in vitro cell/organ culture system including our own might provide easier evaluation of EDC activities and render much clear interpretation on biosynthesis/secretion of cortical steroids and medullary catecholamines.

The reproductive organs such as ovaries and testes are representative examples of sexual dimorphism. On the other hand, it is very difficult to distinguish between male and female adrenal glands in morphological aspect. However, from a functional perspective, adrenal glands are a good example of a non-reproductive sexually dimorphic organ. Indeed, most adrenal lesions occur in females rather than males such as Cushing’s syndrome (Levasseur et al., 2019). In particular, the adrenal cortex is a dynamic portion in which senescent cells are continuously replaced by newly differentiated ones, and this constant renewal facilitates organ remodeling in response to physiological demand for different cortical steroids (Pihlajoki et al., 2015; Kim & Lee, 2022). Therefore, 3 times higher in adrenocortical cell renewal in female rodents appears to be a key mechanism for sexual dimorphism in the adrenocortical morphology and hormone secretion patterns (Lyraki & Schedl, 2021). Previously we demonstrated that low-dose NP treatment induced sexually dimorphic pattern of adrenocortical shrinkage in F1 rats, suggesting the dimorphic pattern of the area-related cortical steroids biosynthesis and/or secretion in the animals (Kim & Lee, 2022). Further, focusing on the dimorphic nature of adrenocortical steroid and/or catecholamines will be a great help not only in gathering basic knowledge but also in understanding the clinical applications. For example, one could try to find the sex-specific nature and cure of adrenal disorders such as Conn syndrome (a hyperaldosteronism occurs when the adrenal glands release too much aldosterone) and Addison’s disease (also called adrenal insufficiency, a condition with too little cortisol or aldosterone).

Conflict of interests

The authors declare no potential conflict of interest.

Acknowledgements

Not applicable.

Authors’ contributions

Con ceptualization: Lee SH.

Data curation: Kim HS, Lee SH.

Formal analysis: Lee SH.

Methodology: Kim HS, Lee SH.

Validation: Cheon YP, Lee SH.

Investigation: Kim HS, Lee SH.

Writing-original draft: Lee SH.

Wr iting-review & editing: Kim HS, Cheon YP, Lee SH.

Ethics approval

All animal experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institute of Health. The animal protocols were approved by the Animal Care and Use Committees at Sangmyung University (2018-03; approval number R-1801-1). All the animals received human care in accordance with the guides for animal experiments of the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.

REFERENCES

1.

Ajdžanović V, Šošić-Jurjević B, Filipović B, Trifunović S, Manojlović-Stojanoski M, Sekulić M, Milošević V. 2009; Genistein-induced histomorphometric and hormone secreting changes in the adrenal cortex in middle-aged rats. Exp Biol Med. 234:148-156.

2.

Chang LL, Wun WSA, Wang PS. 2010; Effects and mechanisms of nonylphenol on corticosterone release in rat zona fasciculata-reticularis cells. Toxicol Sci. 118:411-419

3.

Chang LL, Wun WSA, Wang PS. 2012; Effects of nonylphenol on aldosterone release from rat zona glomerulosa cells. Chem Biol Interact. 195:11-17

4.

Chang LL, Wun WSA, Wang PS. 2018; An inhibitor of 11-β hydroxysteroid dehydrogenase type 1 (PF915275) alleviates nonylphenol-induced hyperadrenalism and adiposity in rat and human cells. BMC Pharmacol Toxicol. 19:45

5.

Chen H, Liu M, Li Q, Zhou P, Huang J, Zhu Q, Li Z, Ge R. 2023; Exposure to dipentyl phthalate in utero disrupts the adrenal cortex function of adult male rats by inhibiting SIRT1/PGC-1α and inducing AMPK phosphorylation. Environ Toxicol. 38:997-1010

6.

Czarnywojtek A, Borowska M, Dyrka K, Moskal J, Kościński J, Krela-Kaźmierczak I, Lewandowska AM, Abou Hjeily B, Gut P, Hoffmann K, Van Gool S, Sawicka-Gutaj N, Ruchała M. 2023; The influence of various endocrine disruptors on the reproductive system. Endokrynol Pol. 74:221-233

7.

Egalini F, Marinelli L, Rossi M, Motta G, Prencipe N, Giaccherino RR, Pagano L, Grottoli S, Giordano R. 2022; Endocrine disrupting chemicals: Effects on pituitary, thyroid and adrenal glands. Endocrine. 78:395-405

8.

Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J, Zoeller RT. 2015; EDC-2: The Endocrine Society’s second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 36:E1:E150

9.

Haeno S, Maeda N, Yamaguchi K, Sato M, Uto A, Yokota H. 2015; Adrenal steroidogenesis disruption caused by HDL/cholesterol suppression in diethylstilbestrol-treated adult male rat. Endocrine. 52:148-156

10.

Harvey PW. 2016; Adrenocortical endocrine disruption. J Steroid Biochem Mol Biol. 155:199-206

11.

Hinson JP, Raven PW. 2006; Effects of endocrine-disrupting chemicals on adrenal function. Best Pract Res Clin Endocrinol Metab. 20:111-120

12.

Kabir ER, Rahman MS, Rahman I. 2015; A review on endocrine disruptors and their possible impacts on human health. Environ Toxicol Pharmacol. 40:241-258

13.

Kim HS, Lee SH. 2022; Effect of nonylphenol on the structure of adrenal cortex in F1 generation rats. Dev Reprod. 26:175-182

14.

Kim YB, Cheon YP, Choi D, Lee SH. 2020; Histological analysis of reproductive system in low-dose nonylphenol-treated F1 female mice. Dev Reprod. 24:159-165

15.

Lagunas N, Fernández-García JM, Blanco N, Ballesta A, Carrillo B, Arevalo MA, Collado P, Pinos H, Grassi D. 2022; Organizational effects of estrogens and androgens on estrogen and androgen receptor expression in pituitary and adrenal glands in adult male and female rats. Front Neuroanat. 16:902218

16.

Lan HC, Lin IW, Yang ZJ, Lin JH. 2015; Low-dose bisphenol A activates Cyp11a1 gene expression and corticosterone secretion in adrenal gland via the JNK signaling pathway. Toxicol Sci. 148:26-34

17.

Lauretta R, Sansone A, Sansone M, Romanelli F, Appetecchia M. 2019; Endocrine disrupting chemicals: Effects on endocrine glands. Front Endocrinol. 10:178

18.

Lee BY, Jo JB, Choi D, Lee SH, Cheon YP. 2021; A chronic-low-dose exposing of DEHP with OECD TG 443 altered the histological characteristics and steroidogenic gene expression of adrenal gland in female mice. Dev Reprod. 25:257-268

19.

Levasseur A, Dumontet T, Martinez A. 2019; Sexual dimorphism in adrenal gland development and tumorigenesis. Curr Opin Endocr Metab Res. 8:60-65

20.

Li X, Li L, Chen X, Li X, Wang Y, Zhu Q, Gao-Smith F, Ge RS. 2020; Triphenyltin chloride reduces the development of rat adrenal cortex during puberty. Food Chem Toxicol. 143:111479.

21.

Lyraki R, Schedl A. 2021; The sexually dimorphic adrenal cortex: Implications for adrenal disease. Int J Mol Sci. 22:4889

22.

Mandon EC, de Gómez Dumm INT, de Alaníz MJT, Marra CA, Brenner RR. 1987; ACTH depresses ∆6 and ∆5 desaturation activity in rat adrenal gland and liver. J Lipid Res. 28:1377-1383

23.

Pihlajoki M, Dörner J, Cochran RS, Heikinheimo M, Wilson DB. 2015; Adrenocortical zonation, renewal, and remodeling. Front Endocrinol. 6:4889

24.

Trejter M, Jopek K, Celichowski P, Tyczewska M, Malendowicz LK, Rucinski M. 2015; Expression of estrogen, estrogen related and androgen receptors in adrenal cortex of intact adult male and female rats. Folia Histochem Cytobiol. 53:133-144

25.

Wood AT, Hall MR. 2000; Reversed-phase high-performance liquid chromatography of catecholamines and indoleamines using a simple gradient solvent system and native fluorescence detection. J Chromatogr B Biomed Sci Appl. 744:221-225

26.

Yanagihara N, Toyohira Y, Ueno S, Tsutsui M, Utsunomiya K, Liu M, Tanaka K. 2005; Stimulation of catecholamine synthesis by environmental estrogenic pollutants. Endocrinology. 146:265-272